Images are still loading please cancel your preview and try again shortly.
Accessibility tools

Private Equity and Financial Sponsors

Linklaters is trusted by the world’s leading private equity houses and financial sponsors to deliver their most important transactions

Private equity and financial sponsors are central to Linklaters’ strategy and have been for many years. The legal directories and league tables consistently rank Linklaters as having one of the leading private equity practices and our clients benefit from our invaluable experience. We advise our clients in a commercial and pragmatic way and support them globally via our 31 offices.

Unlike many of our peers we have leading expertise in private M&A, public M&A, carve-out transactions and IPOs and offer a genuine full-service offering. Clients regularly point to the depth and breadth of our specialist practices as being a key differentiator. Whether it be our financial regulatory team helping a client navigate complex cross-border regulation, our anti-trust team advising on a sensitive price-fixing investigation, our IP team managing complex brand licensing issues on a corporate carve-out or our employment team managing a time-critical transfer of employees, our teams are leaders in their fields.

Our global highlight deals

Hg’s Genesis 7 Fund, Montagu and other selling investors: advising on the sale of a stake in Visma, which values the business at US$12.2bn, to a consortium of investors including Hg Saturn 2 Fund, TPG, Warburg Pincus and CPPIB

Apax: advising on the acquisition and the subsequent sale of shares in Neuraxpharm

Carlyle: advising on the acquisition of Logoplaste

Partners Group: advising the majority shareholder on its entry into exclusive negotiations with EQT Private Equity relating to the disposal of Cerba HealthCare, international leader in the medical biology sector

I Squared Capital: advising on its US$2.15bn purchase of the infrastructure division of GTT Communications, a leading global cloud networking provider to multinational clients

Warburg Pincus and TowerBrook Capital Partners: advising the consortium on the recommended offer for AA, valuing the business at approximately £2.8bn

Carlyle: advising on its £958m recommended cash offer for Vectura Group, a provider of innovative inhaled drug delivery solutions with a premium listing in the UK

Spanish natural gas and electrical energy utilities company: advising on the acquisition financing of an additional 34.05% stake in the owner and operator of a deep sea natural gas pipeline which runs between Algeria and Spain

Apax Partners: advising on the acquisition of Rodenstock from Compass Partners

Global Infrastructure Partners and the Consortium: advising on the $4.73bn recommended cash offer for ordinary share capital of Signature Aviation

CVC: advising on the acquisition of April Group


Nexi: advising Nexi, the Italian payment services firm, on its €2bn IPO – Europe’s largest IPO of 2019

Advent International: advising Advent International on its £4bn offer for Cobham

PAI Partners: advising on the acquisition of Areas

Montagu Private Equity: advising on its $470m global carve-out acquisition of Jane’s Information Group from IHS Markit

BC Partners: advising on the acquisition of 100% of Davies, the leading provider of professional services and technology solutions to the global insurance market, from funds advised by AIMCo, HGGC and Permira, and the management

Macquarie: advising on the sale of the metering service Techem for €4.6bn to a consortium led by the Swiss Partners Group

The Carlyle Group: advising on the sale of PIB Group to Apax Partners and its subsequent re-investment in a minority stake in PIB Group

Everstone Capital, Sunrise BPO Services and ACP Partners: advising on the auction sale of 100% of the Everise Group, a global BPO services provider headquartered in Singapore, to private equity funds managed by Brookfield

PE-backed platform: advising on its US$750m sale-and-leaseback acquisition of more than 4,200 telecommunications towers from PT Indosat Tbk (Indosat Ooredoo), one of Indonesia’s leading digital telecoms providers

Summa Equity: advising on its first transaction in Asia, a control buyout of Sengenics Corporation, a multinational biotech company engaged in advanced precision medicine through proteomics with operations in Malaysia, South Africa, Singapore, Brunei and the UK

x Find a Lawyer